1188428-64-9 Usage
Appearance
White solid The compound is a white solid, which indicates its physical state and color.
Molecular weight
297.92 g/mol The molecular weight of 2,6-dibromo-4-fluoro-3-methylbenzonitrile is 297.92 grams per mole, which is the mass of one mole of the compound.
Industrial applications
Pharmaceutical and agrochemical industries The compound is used as a building block for the synthesis of various organic compounds in both pharmaceutical and agrochemical industries.
Intermediate in production
Dyes and pigments 2,6-dibromo-4-fluoro-3-methylbenzonitrile is utilized as an intermediate in the production of dyes and pigments, which are important for various applications in industries such as textiles, paints, and plastics.
High reactivity
Ability to undergo various chemical reactions The compound is known for its high reactivity, which allows it to participate in a wide range of chemical reactions, making it a versatile compound for the creation of new chemical structures with specialized properties.
Safety concerns
Risks to human health and the environment It is important to handle 2,6-dibromo-4-fluoro-3-methylbenzonitrile with care, as it may pose risks to human health and the environment if not properly managed. This highlights the need for proper safety precautions and waste disposal practices when working with this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 1188428-64-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,8,4,2 and 8 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1188428-64:
(9*1)+(8*1)+(7*8)+(6*8)+(5*4)+(4*2)+(3*8)+(2*6)+(1*4)=189
189 % 10 = 9
So 1188428-64-9 is a valid CAS Registry Number.
1188428-64-9Relevant articles and documents
HIV Integrase Inhibitors
-
Page/Page column 52, (2009/10/17)
The disclosure generally relates to the novel compounds of formula I, including their salts, which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.
